1. Home
  2. INCY vs CFG Comparison

INCY vs CFG Comparison

Compare INCY & CFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Incyte Corp.

INCY

Incyte Corp.

N/A

Current Price

$120.67

Market Cap

23.7B

Sector

Health Care

ML Signal

N/A

Logo Citizens Financial Group Inc.

CFG

Citizens Financial Group Inc.

N/A

Current Price

$63.79

Market Cap

26.9B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
INCY
CFG
Founded
1991
1828
Country
United States
United States
Employees
2844
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
23.7B
26.9B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
INCY
CFG
Price
$120.67
$63.79
Analyst Decision
Buy
Buy
Analyst Count
28
20
Target Price
★ $130.63
$76.39
AVG Volume (30 Days)
1.8M
★ 4.4M
Earning Date
10-29-2026
10-16-2026
Dividend Yield
N/A
★ 3.16%
EPS Growth
★ 4173.33
27.39
EPS
0.50
★ 3.83
Revenue
$3,394,635,000.00
★ $8,247,000,000.00
Revenue This Year
$18.06
$11.18
Revenue Next Year
$3.30
$8.69
P/E Ratio
$79.26
★ $17.15
Revenue Growth
★ 13.67
5.61
52 Week Low
$89.25
$49.00
52 Week High
$132.60
$75.33

Technical Indicators

Market Signals
Indicator
INCY
CFG
Relative Strength Index (RSI) 56.42 41.39
Support Level $115.77 $61.84
Resistance Level $130.53 $64.03
Average True Range (ATR) 3.63 1.35
MACD 0.95 0.29
Stochastic Oscillator 79.39 36.89

Price Performance

Historical Comparison
INCY
CFG

About INCY Incyte Corp.

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.

About CFG Citizens Financial Group Inc.

Citizens Financial Group Inc is a bank holding company headquartered in Providence, Rhode Island. Through its subsidiaries, it offers various retail and commercial banking products and services to individuals, small businesses, middle-market companies, large corporations, and institutions. The group's reportable business segments are: Consumer Banking and Commercial Banking. The majority of its revenue is generated from the Consumer Banking segment, which serves consumer customers and small businesses, offering traditional banking products and services, including deposits, mortgage and home equity lending, credit cards, small business loans, education loans, point-of-sale finance loans, and wealth management solutions, among others, through a network of branches and ATMs.

Share on Social Networks: